Background Several high-income countries have pre-entry screening programmes for tuberculosis. We aimed to establish the yield of pre-entry screening programmes to inform evidence-based policy for migrant health screening.
Introduction
Several high-income countries (Australia, Austria, Canada, France, Israel, Jordan, New Zealand, and USA) have pre-entry screening programmes for tuberculosis. 1 The UK has used a combination of upon-entry and post-entry screening for several decades, but fully transitioned to pre-entry screening on April 1, 2014. 2 Migration patterns have led to recent changes in the epidemiological profi le of cases in low-incidence settings. In Europe there has been an absolute decrease in the number of tuberculosis cases reported, but only fi ve countries report a decrease in migrant populations, ten report no change, and 11 report an increase. 3, 4 The overall proportion of tuberculosis cases in individuals of foreign origin in Europe is 25·8%; however, many countries have much higher proportions, such as Sweden (89·4%), Norway (87·8%), and the UK (70·1%). 5, 6 In the USA, the overall number of tuberculosis cases has been decreasing, but notifi cations in foreign-born individuals are 11·5 times higher than those born in the country. 7 The number of people residing outside their country of birth is substantial. The UN Population Division estimated that globally this population consisted of 232 million people in 2013. 8, 9 Between 1990 and 2013, North America accepted the largest gross infl ow of migrants at 25 million, and Europe had the second largest at 23 million. A substantial number of migrants move from countries with a high incidence of tuberculosis to those with a low incidence. Reasons for migration include economics (to work in the receiving country or move away from fi nancial crises in the country of origin), education, political instability or war, natural disasters, and reunion (joining family members in the receiving country). 10, 11 Because of the high burden of tuberculosis in migrants, many governments in low-incidence settings have implemented screening programmes. Tuberculosis screening programmes for migrants can occur at three points in time: pre-entry (before entering the country), upon entry, or post-entry. Many European countries have implemented post-entry screening and, although there are diff erences in the screening approach, the characteristics of such programmes are well documented. 12 The yield of pre-entry screening programmes for tuberculosis can diff er from upon-entry and post-entry programmes. With some exceptions, upon-entry and post-entry screening tend not to be a compulsory part of visa applications; therefore, individuals undergoing screening might not be representative of the wider migrant population. Attendance for screening could be determined by patient health-seeking behaviour or the opinion of immigration staff . Conversely, pre-entry screening programmes are typically a compulsory part of the visa application process and as a result coverage is higher, if not complete, and such studies should be fully representative of the populations screened and intending to migrate.
The characteristics of post-entry and upon-entry screening programmes have been well documented, but we are not aware of any previous studies that have systematically reviewed the yield of pre-entry screening programmes. [12] [13] [14] Therefore, our aim was to establish the yield of pre-entry screening programmes for active disease and latent infection to inform future evidence-based policy for migrant health-screening initiatives.
Methods

Search strategy and selection criteria
We searched for reports published after Jan 1, 1980, in Medline, Embase, LILACS, Cochrane Infectious Diseases Group Specialized Register, Cochrane Library, Conference Proceedings Citation Index-Science, and Conference Proceedings Citation Index-Social Science & Humanities. Reference lists of included studies were hand-searched to identify further relevant work.
Detailed search terms for the bibliographic databases are presented in the appendix. In summary, terms covered the populations of interest (migrants, refugees, asylum seekers, new entrants, undocumented migrants), the intervention (pre-entry screening), and standard terms for tuberculosis.
Initial search results were imported into EPPI-Reviewer 4 where duplicates were identifi ed and removed. An updated search was done on April 1, 2014, with Zotero. 15, 16 RWA, TAY, and DZ screened titles, abstracts, and full-text reports. Disagreements were resolved by discussion, and remaining issues were assessed in conjunction with a fourth reviewer (ACH). Data from included studies were extracted in duplicate to an Excel spreadsheet (Microsoft Offi ce for Mac 2011).
We prespecifi ed several study types as eligible for inclusion: experimental studies (randomised controlled trials and quasi-randomised controlled trials, including before and after studies), observational studies (including retrospective and prospective cohort studies, case-control studies, cross-sectional and case series), and systematic reviews. Additional inclusion criteria were that a study needed to be published with an abstract in English, it needed to report the total number of individuals screened who plan to migrate and the number of cases of tuberculosis infection or disease identifi ed, and screening needed to have taken place before the migrant entered a low-incidence country. Eligible studies could screen for tuberculosis by any method including radiographic, microbiological, and a clinician's recommendation to treat an individual on the basis of clinical or radiological signs or symptoms compatible with tuberculosis. We followed the PRISMA reporting guidelines.
Defi nitions
We used the defi nition of migrants developed by Hans Rieder and colleagues 17 and used in a recent systematic review of screening in the European Union. 12 It classifi es migrants into the four groups: migrant (a foreigner legally admitted and expected to settle in a host country), asylum seeker (a person wishing to be admitted to a country as a refugee and awaiting decision on their application for refugee status under relevant international instruments), foreign-born citizen (a person who is a national of the state in which they are present but who was born in another country), and undocumented foreigner or migrant (formerly classifi ed as illegal, describing an individual who enters, stays, or works in a host country without an appropriate residence permit or visa).
There is no universally accepted defi nition of a low-incidence tuberculosis country. For the purpose of our analysis, we used the European Centre for Disease Prevention and Control defi nition of a low-incidence country as one with a notifi cation rate below 20 cases per 100 000 in the general population. 18
Outcomes
We considered three primary outcomes: the principal yield of pre-entry screening for active tuberculosis reported for each study (detected by any method), yield of active tuberculosis cases confi rmed by culture, and yield of active tuberculosis cases confi rmed by smear for *Limitations in sputum smear and culture methods were reported by study authors. †Full defi nition not provided and unable to contact corresponding author. ‡Symptomatic patient with pulmonary disease and confi rmed Mycobacterium tuberculosis complex culture. §Following the results of chest radiograph, applicants were invited to participate in a study of the tuberculin skin test and QuantiFERON-TB Gold In-Tube Assay for which they would be provided the results, but the result of which would not aff ect their visa application; varying size of the tuberculin skin test induration was used as cutoff . ¶Yield for latent tuberculosis for this study is not presented since the primary aim of the study was to compare the sensitivity of QuantiFERON-TB Gold In-Tube Assay with the tuberculin skin test for culture-positive pulmonary tuberculosis; therefore, it was done on a sample of migrants with and without abnormal radiograph results, and therefore yield of latent tuberculosis will not be representative. ||Inactive tuberculosis defi ned by authors as "radiograph shows evidence of tuberculosis, it is repeated at a minimum interval of 3 months to confi rm stability of the lesion. In addition, three sputum cultures, incubated for 7-8 weeks, taken at least 24 h apart, are required to be negative". 
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Statistical analysis
We used fi xed-eff ects models with Freeman-Tukey transformation of data to estimate summary yield of pre-entry screening across studies and subgroups where appropriate. 20, 21 We used the I² transformation to describe the proportion of total variation in study estimates that is due to heterogeneity. 22 Where we identifi ed overlapping data on an individual screening programme, we included the publication with the largest amount of data (by time period or number of individuals screened). Where appropriate, we presented economic components of the studies in a narrative format.
We did a subgroup analysis for the primary outcomes to assess the eff ect of prevalence in the country of origin, the screening method used (eg, radiographic, microbiological, clinical), the receiving country, and the type of migrants screened. Because there are no universally accepted categories to classify prevalence of tuberculosis at the country level, we chose to use the following groups: 20-49, 50-149, 150-249, 250-349, and 350 or more cases per 100 000 population. We used WHO prevalence estimates for the middle year in which screening was done. 23 Where possible, we extracted data for primary outcomes for each of the subgroups (eg, diff erent countries of origin) and then included them in the subgroup analysis.
RWA and TAY independently assessed the risk of bias for included studies with the Grading of Recommendations Assesssment, Development, and Evaluation (GRADE) approach. 24 Any disagreements were discussed and resolved with the help of a third reviewer (ACH) where necessary.
Role of the funding source
The study sponsors had no role in study design, the collection, analysis, and interpretation of data. The corresponding author confi rms that he had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. 
Results
A search of six bibliographic databases was done on April 5, 2013, and updated on April 1, 2014. 1887 studies were identifi ed (fi gure 1). 15 more reports were identifi ed through other sources, including the review of references of included studies. 157 full-text articles were retrieved and assessed for eligibility, and 19 manuscripts met the inclusion criteria after double screening and review. [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] After further review and extraction of data, four studies were excluded from the fi nal analysis because they contained overlapping data for the primary outcomes. [40] [41] [42] [43] The 15 studies included in the fi nal analysis reported data on 3 739 266 individual migrants screened between 1982 and 2010 (table 1). [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] The smallest study had data on 873 migrants and the largest 3 092 729 migrants. Screening protocols varied between studies, but many included an initial chest radiograph, clinical examination, and testing for smear and culture. The principal outcome for ten studies reporting data on active tuberculosis included a combination of smear, culture, or intention to treat on the basis of clinical fi ndings as part of their case defi nition (fi gure 2). Meta-analyses of yield for all three primary outcomes showed high levels of heterogeneity (I²>90%) and therefore we did not calculate summary eff ect estimates across studies.
No studies reported the number of individuals tested by sputum culture or smear and therefore it was only possible to calculate yield based on the total number of individuals screened, and not by total number of microbiological tests done (table 2) . Six studies presented data on 755 cases that were culture confi rmed among 452 971 individuals initially screened. 27, 28, [31] [32] [33] [34] [35] Six studies had data on smear-positive cases of tuberculosis, with 987 cases identifi ed in the 569 210 individuals initially screened. 25, 26, 28, 32, 34, 36 Most studies reported sputum smear testing on three samples for those individuals with radiograph or clinical symptoms that suggested tuberculosis (appendix). Some variation existed in the number of positive samples needed to classify individuals with smear-positive disease.
After stratifying results by prevalence of tuberculosis in the country of origin, heterogeneity was reduced for culture-positive and smear-positive confi rmed cases, but not the principal outcome-active tuberculosis cases (fi gure 3, appendix). There was an increasing yield of culture-positive and smear-positive cases with increasing prevalence in the country of origin. Summary estimates of yield of culture-positive cases ranged from 19·7 (95% CI 10·3-31·5) cases identifi ed per 100 000 individuals screened in countries with a prevalence of 50-149 cases per 100 000 population to 335·9 (283·0-393·2) per 100 000 in countries with a prevalence of greater than 350 per 100 000 population (fi gure 3). The results of the meta-analyses were dominated by one large study, which acknowledged some limitations with data for smear and culture testing because this was not uniformly done across all sites and for all cases. 28 Across all included studies, prevalence of culture-confi rmed cases was highest in migrants to the USA from Vietnam with 1298 cases per 100 000 individuals screened (95% CI 1118-1499; appendix). Yield per 100 000
50−149 cases per 100 000 population
King et al, 28 With the exception of culture-confi rmed cases in refugees (I²=0%, p=0·85), heterogeneity remained high for all three primary outcomes (I²>90%) after stratifying by population, screening method, and receiving country (full results are presented in the appendix).
In the studies that reported data on culture-confi rmed cases, three described yield of multidrug-resistant tuberculosis. 33 cases in 183 individuals with cultureconfi rmed disease were found in these three studies. 28, 32, 34 Although most studies had radiographic screening as a fi rst-line test, numerator and denominator data for this specifi c outcome were only presented in fi ve studies. 27, 30, 32, 33, 38 34 495 chest radiograph-positive cases were reported among the 3 154 873 individuals screened, and probably included both active and inactive (or old) tuberculosis. Not all studies provided details as to how radiographs were analysed and classifi ed, which might result in a great deal of variation between studies.
Three studies reported data on latent tuberculosis infection, with 1884 latent infections identifi ed in 20 587 individuals screened (varying tests and cutoff s were used-see appendix). 29, 34, 39 One study reported tests for latent tuberculosis on a sample of migrants on the basis of radiograph results (testing 1000 applicants with radiographic fi ndings consistent with active tuberculosis and 500 applicants with a normal radiograph). Therefore, the yield of latent tuberculosis from this study does not represent population prevalence of latent tuberculosis infection and the results were not included in this secondary analysis. 35 Cost-eff ectiveness was examined in one study with data from the Canadian pre-entry migrant screening pro gramme from June, 1996, to June, 1997. Compared with passive detection of cases after arrival in Canada, this study estimated the incremental cost (savings) to treat each case of prevalent active tuberculosis detected pre-entry as CAN$39 409. 27 A further study, using data presented in this systematic review, 33 estimated the cost of running a health station for an active tuberculosis screening programme in Ethiopia at US$60 100 for about 3500 individuals screened per annum. 44 No data were found on costs of treatment for individuals screened and identifi ed as having tuberculosis.
We used GRADE criteria to assess the risk of bias of included studies (table 3) . All included studies were observational in nature and therefore the evidence for each outcome was initially determined as low (as per the GRADE methodology). This systematic review focuses on describing yield of existing screening programmes in operational settings and therefore observational studies are an appropriate study design. Most studies were at risk of bias because of the eligibility criteria applied, and the reporting and measure ment of exposure and outcome data. Substantial heterogeneity existed for primary outcomes, with CIs across studies showing minimal or no overlap with the exception of culture-confi rmed and smearconfi rmed disease when stratifi ed by prevalence in country of origin. Because of these limitations, the quality of evidence for all outcomes was downgraded to very low.
Discussion
We identifi ed data on nearly 4 million migrants screened pre-entry and found that yield for culture-confi rmed and †Most studies were at some risk of bias for failure to develop and apply appropriate eligibility criteria and measurements of outcome that had limitations. ‡Largest study for analysis by subgroup 28 stated that "smear and culture testing may be off ered but of variable quality". Several studies only look back at results of individuals who arrived in the low-incidence country-a potential bias if there was a diff erence in the proportion who travelled by test result, which is likely to be the case. §Substantial heterogeneity existed among studies with CIs that minimally overlapped. The proportion of the variation in point estimates due to among-study diff erences was large and exploration of a-priori subgroup analyses did not substantially explain this. ¶Populations across studies varied; however, the evidence summaries are highly relevant to policy makers and those interpreting the studies, and outcomes (such as active tuberculosis) are likely to be of interest and important to migrants. ||Interventions and outcomes varied greatly, particularly as smear and culture testing was off ered but of variable quality in the largest included study for analysis by subgroup 28 and as many studies included radiographic diagnoses with substantial variation in the radiographic case defi nition used. Additionally, studies with high detection rates (Watkins et al 38 ) seem likely to have included inactive and old tuberculosis scars in addition to active disease. **Data for all years from countries conducting pre-entry screening were not available in the published literature. † †Some evidence to suggest that higher tuberculosis prevalence in country conducting pre-entry screening was associated with a higher yield of cases. ‡ ‡There was the potential for outbreak bias in one study 34 because it was initiated as a result of an unusually high number of cases. § §Substantial heterogeneity among studies with CIs that showed minimal or no overlap. The proportion of the variation in point estimates due to between-study diff erences was large. Exploration of a-priori subgroups reduced heterogeneity. ¶ ¶Interventions and outcomes for multidrug-resistant cases are likely to be less variable due to procedures involved in laboratory testing being somewhat uniform across sites, although the consistency with which these were applied across studies might cause some issues in relation to indirectness. Table 3 : GRADE summary of fi ndings and quality of evidence for the primary and secondary outcomes smear-confi rmed cases was highest when screening was done in high-prevalence countries. Only two studies presented data on the associated costs or cost eff ectiveness of their pre-entry screening programme. To our knowledge, this is the fi rst systematic review and metaanalysis of pre-entry screening programme data for tuberculosis, which identifi ed 15 studies with unique data on this topic. We used established systematic review procedures including double screening review, and PRISMA reporting guidelines for systematic reviews and meta-analyses. 19 We attempted to reduce bias in the review process by following empirically based review guidelines. 24 There was substantial heterogeneity between studies, limiting our ability to synthesise results across settings and outcomes. With the exception of yield of culture-confi rmed and smear-confi rmed cases, when stratifi ed by prevalence of tuberculosis in country of origin, and culture-confi rmed cases in refugees, heterogeneity in the primary and secondary outcomes remained high after exploring potential a-priori explanatory variables. Data on the age of those screened was not provided consistently, which might be particularly important for latent tuberculosis and studies that included old tuberculosis detected by chest radiograph. The top fi ve countries of origin for migrants from developing to developed countries in 2010 were Mexico, India, China, Philippines, and Turkey. 11 Although data are presented for India, China, and the Philippines, the migrants are not entirely representative of migrant fl ow between developing and developed countries. It was not clear from most studies whether there was uniform drug susceptibility testing or whether only retreatment cases were tested. There was a risk of misclassifi cation in the principal outcomes reported by many studies, particularly for those that included clinically identifi ed cases (with an intention to treat) as part of the case defi nition.
A previously published systematic review focused on all types of migrant screening programmes for tuberculosis in the European Union and European Economic Area, independent of where the screening took place. 12 The review by Klinkenberg and colleagues 12 did not identify any studies of pre-entry screening by European countries; however, data were separately reported from three preentry screening programmes performed by countries outside the European Union and European Economic Area. All studies of non-European Union studies were identifi ed and included in our systematic review. A total of 14 studies reported data from upon-entry screening programmes in the European Union and European Economic Area with a median active tuberculosis yield of 360 (IQR 100-520) cases per 100 000 people screened. Five studies reported data on community post-entry screening with a summary median active tuberculosis yield of 220 (IQR 100-380) cases per 100 000 people invited to screening. Direct comparisons with upon-entry and post-entry screening programmes are diffi cult to make because of the lack of comparability between study designs, secular trends, and the populations considered. Pre-entry screening, when done in countries with a prevalence of tuberculosis greater than 350 per 100 000 population seems to be within a similar range as these upon-entry and post-entry programmes.
Pre-entry screening programmes aim to identify cases of active tuberculosis before arrival of the migrant in the host country. Our review provides evidence that pre-entry screening programmes have varying yield that increases with prevalence in the country of origin. Screening in countries with prevalence of less than 150 per 100 000 will probably result in low yield of culture-confi rmed and smear-confi rmed cases.
Pre-entry screening programmes might need the migrant to cover the bulk of costs of testing and treatment; however, the programmes still might not be entirely cost-neutral for the receiving country because of the governance and oversight needed for appropriate operation. The paucity of cost-eff ectiveness data on these schemes should therefore be addressed because there is uncertainty of the value of pre-entry screening compared with other tuberculosis control activities.
Data from surveillance programmes around the world suggest that rates of disease in migrants from high-incidence countries remain high for many years after entry, so tuberculosis control programmes in low-incidence countries should not rely entirely on pre-entry screening for active tuberculosis in migrants. 7, [45] [46] [47] For example, in the UK, 50% of tuberculosis in migrant groups occurs more than 5 years after entry. 6 Additionally, these schemes could miss tuberculosis following unplanned migration and in undocumented migrants who might have higher risk. Health care provision for migrants after arrival to a host country and other tuberculosis control measures should therefore remain a priority, because screening migrants will not prevent a high proportion of future cases of disease.
Emerging evidence suggests that domestic returns for investment in tuberculosis control programmes overseas might make them cost eff ective, and policy makers might wish to consider implementation alongside pre-entry screening programmes. 48, 49 Such an enlightened self-interest approach to global tuberculosis control might be not only more cost eff ective, but also could overcome screening-induced inequalities, so that a greater number of individuals in need benefi t from treatment, not just those in a position to leave their country of origin. This broader view would enhance global collaboration in eff orts to eliminate tuberculosis.
In many low-incidence countries, risk of tuberculosis is greatest in migrant populations. Some of this disease can be identifi ed by pre-entry screening with the highest yield achieved when programmes focus on high-prevalence countries. Pre-entry screening might therefore make a contribution to control within the receiving country, but the cost-eff ectiveness remains unclear and where the cost of screening is borne by the migrant or their country of origin this might increase inequalities. When used, pre-entry screening should therefore be considered as part of a broader package of measures to ensure early diagnosis and eff ective management of migrants with active tuberculosis, and be integrated with other initiatives addressing the health needs of migrants.
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